---
title: Beta-Blocker Interruption or Continuation after Myocardial Infarction
date: '2024-08-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39213187/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240831181357&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: In patients with a history of myocardial infarction, interruption
  of long-term beta-blocker treatment was not found to be noninferior to a strategy
  of beta-blocker continuation. (Funded by the French Ministry of Health and ACTION
  Study Group; ABYSS ClinicalTrials.gov number, NCT03498066; EudraCT number, ...'
disable_comments: true
---
CONCLUSIONS: In patients with a history of myocardial infarction, interruption of long-term beta-blocker treatment was not found to be noninferior to a strategy of beta-blocker continuation. (Funded by the French Ministry of Health and ACTION Study Group; ABYSS ClinicalTrials.gov number, NCT03498066; EudraCT number, ...